Transoral robotic surgery (TORS) for laryngeal and hypopharyngeal cancers

Abstract

Transoral robotic surgery (TORS) is increasingly used in laryngeal/hypopharyngeal cancer surgery. Ablative procedures described in these anatomical sites include: (i) supraglottic laryngectomy, (ii) total laryngectomy, (iii) glottic cordectomy, and (iv) partial pharyngectomy. TORS supraglottic laryngectomy remains the most commonly performed of these procedures. Initial oncologic and functional outcomes with these procedures are promising and comparable to other treatment options. As robotic instrumentation technology advances a rise in TORS laryngeal/hypopharyngeal surgery is anticipated.

Small cell carcinoma of the head and neck: A comparative study by primary site based on population data

“…With improved endoscopic techniques and surgical access, there has been significant interest and progress made in minimally invasive, transnasal resection of sinonasal and anterior skull base malignancies . Similarly, we are currently seeing the beginning of a paradigm shift toward minimally invasive, transoral techniques for treatment of laryngeal malignancies . In both models, function and quality of life are better preserved as compared to traditional, open approaches.…”

“…[5][6][7][8][9] Similarly, we are currently seeing the beginning of a paradigm shift toward minimally invasive, transoral techniques for treatment of laryngeal malignancies. 10,11 In both models, function and quality of life are better preserved as compared to traditional, open approaches. These techniques continue to gain in prominence and have subsequently changed the way we manage traditionally difficult-to-access malignancies regardless of pathology.…”

Transoral supraglottic laryngectomy using a next‐generation single‐port robotic surgical system

“…In open SGL, the epiglottis, false vocal cords, and superior half of the thyroid cartilage is resected. For TORS SGPL, the thyroid cartilage is preserved . Extended superior resection to include the hyoid and extended lateral resection including the pyriform sinus were not attempted in this study.…”

Robotic surgical systems in maxillofacial surgery: a review

“…Later, O’Malley and colleagues 14 reported the technical feasibility of robot-assisted surgery for base of tongue (BOT) neoplasm resection; Weinstein and colleagues 15 successfully performed a robot-assisted radical tonsillectomy in 2007 after cadaveric robotic surgery. With this much groundwork completed, several studies subsequently focused on the application of TORS in various types of neoplasms, including squamous cell carcinoma, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59 mucoepidermoid carcinoma, 16, 35, 43, 50, 60, 61 malignant melanoma, 62 synoviosarcoma, 33, 63 adenoid cystic carcinoma, 33, 35, 43, 50, 60, 64 pleomorphic adenoma, 32, 35, 47, 65 lipoma 33 and neurilemmoma. 64 …”